Irinotecan-encapsulated double-reverse thermosensitive nanocarrier system for rectal administration

Intravenously administered for the treatment of rectum cancer, irinotecan produces severe side effects due to very high plasma concentrations. A novel irinotecan-encapsulated double reverse thermosensitive nanocarrier system (DRTN) for rectal administration was developed as an alternative. The DRTN...

Descripción completa

Detalles Bibliográficos
Autores principales: Din, Fakhar ud, Choi, Ju Yeon, Kim, Dong Wuk, Mustapha, Omer, Kim, Dong Shik, Thapa, Raj Kumar, Ku, Sae Kwang, Youn, Yu Seok, Oh, Kyung Taek, Yong, Chul Soon, Kim, Jong Oh, Choi, Han-Gon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241086/
https://www.ncbi.nlm.nih.gov/pubmed/28181835
http://dx.doi.org/10.1080/10717544.2016.1272651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241086/
https://www.ncbi.nlm.nih.gov/pubmed/28181835
http://dx.doi.org/10.1080/10717544.2016.1272651

Ejemplares similares